Cambrex completed an investment project at its facility in Tallinn, Estonia to upgrade its kilogram-scale lab for the manufacture of pharmaceutical intermediates under current good manufacturing practice (CGMP) conditions.
On the day the state of emergency was declared in Estonia, a public-private e-hackathon was held as one of the first crisis responses to offer quick and feasible solutions to combat the impacts of COVID-19 outbreak.